Second generation hyper-active micro-dystrophin AAV vectors for Duchenne muscular dystrophy gene therapy

Project: Research

StatusFinished
Effective start/end date1/10/1530/09/18

Funding

Muscular Dystrophy Campaign: £59,965, Muscular Dystrophy Campaign: £57,679, Muscular Dystrophy Campaign: £56,456

ID: 25229864